JP2016520585A5 - - Google Patents

Download PDF

Info

Publication number
JP2016520585A5
JP2016520585A5 JP2016512879A JP2016512879A JP2016520585A5 JP 2016520585 A5 JP2016520585 A5 JP 2016520585A5 JP 2016512879 A JP2016512879 A JP 2016512879A JP 2016512879 A JP2016512879 A JP 2016512879A JP 2016520585 A5 JP2016520585 A5 JP 2016520585A5
Authority
JP
Japan
Prior art keywords
molecule according
collagen molecule
chondroitin sulfate
collagen
pxg
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2016512879A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016520585A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/SG2014/000204 external-priority patent/WO2014182249A1/en
Publication of JP2016520585A publication Critical patent/JP2016520585A/ja
Publication of JP2016520585A5 publication Critical patent/JP2016520585A5/ja
Pending legal-status Critical Current

Links

JP2016512879A 2013-05-09 2014-05-09 修飾コラーゲン分子 Pending JP2016520585A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SG2013035977 2013-05-09
SG201303597-7 2013-05-09
PCT/SG2014/000204 WO2014182249A1 (en) 2013-05-09 2014-05-09 Modified collagen molecules

Publications (2)

Publication Number Publication Date
JP2016520585A JP2016520585A (ja) 2016-07-14
JP2016520585A5 true JP2016520585A5 (enExample) 2017-06-15

Family

ID=51867585

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016512879A Pending JP2016520585A (ja) 2013-05-09 2014-05-09 修飾コラーゲン分子

Country Status (6)

Country Link
US (1) US20160075765A1 (enExample)
EP (1) EP2994484A4 (enExample)
JP (1) JP2016520585A (enExample)
CN (1) CN105392799A (enExample)
SG (1) SG11201509238WA (enExample)
WO (1) WO2014182249A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102955766B1 (ko) 2018-05-03 2026-04-22 콜플랜트 리미티드 진피 충전제 및 이의 적용
CN116410302B (zh) * 2023-02-21 2025-09-12 汤臣倍健股份有限公司 一种富糖胺聚糖胶原蛋白肽的应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2672587B2 (ja) * 1988-08-23 1997-11-05 生化学工業株式会社 新規ix型コラーゲン、それを構成する新規超高分子コンドロイチン硫酸及びそれらの製造法
US5475052A (en) * 1988-11-21 1995-12-12 Collagen Corporation Collagen-synthetic polymer matrices prepared using a multiple step reaction
US5866165A (en) * 1997-01-15 1999-02-02 Orquest, Inc. Collagen-polysaccharide matrix for bone and cartilage repair
US6780841B2 (en) * 2001-11-13 2004-08-24 Biocell Technology, Llc Hyaluronic acid and chondroitin sulfate based hydrolyzed collagen type II and method of making same
US20060067959A1 (en) * 2004-09-28 2006-03-30 Marcel Nimni Compositions and methods for treatment of solar damage
US8283414B2 (en) * 2004-11-23 2012-10-09 The Johns Hopkins University Compositions comprising modified collagen and uses therefor
KR20100052499A (ko) * 2007-08-01 2010-05-19 에디컨인코포레이티드 콜라겐-관련 펩티드 및 이의 용도
US20090068250A1 (en) * 2007-09-07 2009-03-12 Philippe Gravagna Bioresorbable and biocompatible compounds for surgical use
US20120122791A1 (en) * 2009-05-01 2012-05-17 Jnc Corporation Substrate for cartilage cultivation using artificial collagen, and method for cartilage regeneration treatment using the substrate
US9217016B2 (en) * 2011-05-24 2015-12-22 Symic Ip, Llc Hyaluronic acid-binding synthetic peptidoglycans, preparation, and methods of use
WO2013023137A2 (en) * 2011-08-10 2013-02-14 William Marsh Rice University Multi-hierarchical self-assembly of a collagen mimetic peptide
JP6051619B2 (ja) * 2012-06-29 2016-12-27 Jnc株式会社 コラーゲン様ポリペプチドの製造方法

Similar Documents

Publication Publication Date Title
NZ624749A (en) A sulfated polysaccharide compound and the preparation and use thereof
HK1206297A1 (en) Pharmaceutical compositions for combination therapy
WO2017132432A8 (en) Benzimidazole derivatives as modulators of ror-gamma
CY1122189T1 (el) Ιονικες υδατικες συνθεσεις
WO2017087608A8 (en) Modulators of ror-gamma
CY1119252T1 (el) Νεα παραγωγα 1-βενζυλο-3 -υδροξυμεθυλινδαζολης και χρηση αυτων στη θεραπεια νοσων που βασιζονται στην εκφραση των cx3cr1 και ρ40
BRPI0912411B8 (pt) uso de uma muteína de interleucina humana-2 (muteína de hil-2) e composição farmacêutica para o tratamento e/ou profilaxia de uma doença autoimune
CY1119880T1 (el) Παραγωγα πυρρολοπυριμιδινης για χρηση στη θεραπεια ιικων λοιμωξεων
EP2540284A3 (en) Compositions and methods for stabilized polysaccaride formulations
PL2173324T3 (pl) Zastosowanie żelu z polisacharydu(ów) naturalnego(ych) do wytwarzania kompozycji do wstrzykiwania w celu leczenia zwyrodnień stawów
CY1118947T1 (el) Ασυμμετρες ουριες και ιατρικες χρησεις αυτων
CY1119007T1 (el) Συνθεσεις και μεθοδοι αγωγης πνευμονικης υπερτασης
BR112018004536A2 (pt) peptídeos de endereçamento à cartilagem
BR112014021498A2 (pt) composto, composição e método para tratar uma doença associada com formação de dna circular covalentemente fechado
BRPI0915084A2 (pt) composto, processo para a preparação de um composto, composição farmacêutica, uso de um composto, métodos para a profilaxia ou tratamento de um estado de doença ou uma condição e de câncer
MX2009008531A (es) Cetonas de heterociclilo que contienen nitrogeno y su uso como inhibidores de c-met.
BRPI1008974A2 (pt) composto, composição farmacêutica, e, método para tratar, prevenir ou melhorar uma doença mediada com gsk-3
EA201200143A1 (ru) Антибактериальная композиция для ротовой полости
EA201391486A1 (ru) Способы и композиции для лечения болезни паркинсона
BR112013004436A2 (pt) composições e usos de materiais com atividade microbicida alta e toxicidade baixa
MX363923B (es) Composicion de farmaco de carbohidrato novedoso para el tratamiento de enfermedades humanas.
MY149505A (en) Hyaluronic acid binary mixtures and therapeutic use thereof
FI2034956T4 (fi) Matalan viskositeetin omaavia glykosaminoglykaaneja käsittäviä koostumuksia ja mainitun koostumuksen käyttö kroonisen kystiitin terapiassa
WO2017062468A8 (en) Ppar agonists, compounds, pharmaceutical compositions, and methods of use thereof
CY1114735T1 (el) Θεραπευτικες συνθεσεις οι οποιες περιεχουν εναν ειδικο ανταγωνιστη του υποδοχεα της ενδοθηλινης και εναν αναστολεα της pde5